Edgewise Therapeutics
EWTX
253 hedge funds and large institutions have $5.08B invested in Edgewise Therapeutics in 2026 Q3 according to their latest regulatory filings, with 47 funds opening new positions, 104 increasing their positions, 71 reducing their positions, and 19 closing their positions.
147% more first-time investments, than exits
New positions opened: 47 | Existing positions closed: 19
105% more capital inflows, than outflows
Capital inflows: $998M | Capital outflows: $487M
46% more repeat investments, than reductions
Existing positions increased: 104 | Existing positions reduced: 71
15% more funds holding in top 10
Funds holding in top 10: 13 → 15 (+2)
12% more funds holding
Funds holding: 226 → 253 (+27)
5.39% more ownership
Funds ownership: 109.75% → 115.15% (+5.4%)
3% less call options, than puts
Call options by funds: $23.7M | Put options by funds: $24.5M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$89.3M |
| 2 |
First Light Asset Management
Edina,
Minnesota
|
+$59M |
| 3 |
Marshall Wace
London,
United Kingdom
|
+$53.1M |
| 4 |
Deep Track Capital
Greenwich,
Connecticut
|
+$48.8M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$44M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$192M |
| 2 |
Cormorant Asset Management
Boston,
Massachusetts
|
-$27.6M |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
-$22.4M |
| 4 |
AllianceBernstein
Nashville,
Tennessee
|
-$16.4M |
| 5 |
SL
Siren LLC
Greenwich,
Connecticut
|
-$16.2M |
EWTX Hedge Fund Activity: Q3 2026 in Review
253 of the 8,227 institutional investors tracked by Wall St. Rank reported a position in Edgewise Therapeutics (EWTX) for Q3 2026, worth a combined $5.08B — up 5.3% from $4.82B a quarter earlier.
Buyers outnumbered sellers: 47 funds opened new EWTX positions and 19 closed out — a net gain of 28 holders — while 104 added to existing stakes and 71 trimmed.
The largest buyer was Citadel Advisors, adding an estimated $89.3M. The largest seller was Fidelity Investments, cutting an estimated $192M.
- 253 institutional investors held Edgewise Therapeutics (EWTX) as of Q3 2026, up from 226 in Q2 2026.
- Funds reported $5.08B of Edgewise Therapeutics stock for Q3 2026, up 5.3% quarter-over-quarter.
- 47 funds opened new Edgewise Therapeutics positions in Q3 2026 and 19 closed out, a net change of +28 holders.
- The largest Edgewise Therapeutics buyer in Q3 2026 was Citadel Advisors, an estimated $89.3M added.
- The largest Edgewise Therapeutics seller in Q3 2026 was Fidelity Investments, an estimated $192M sold.
Based on aggregated 13F filings for Q3 2026.